Comparing the use of novel immunotherapeutic approaches with standard chemotherapy in the frontline setting represents a key focus of research in the endometrial cancer paradigm, according to Bradley R. Corr, MD.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045